The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account
Author:
Affiliation:
1. Institute for Virology and Immunobiology; University of Würzburg; Germany
Funder
TeGenero
TheraMab
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/febs.13754/fullpdf
Reference56 articles.
1. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28;Tacke;Eur J Immunol,1997
2. Efficient expansion of regulatory T-cells in vitro and in vivo with a CD28 superagonist;Lin;Eur J Immunol,2003
3. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis;Beyersdorf;J Exp Med,2005
4. Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody;Rodriguez-Palmero;J Rheumatol,2006
5. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies;Schmidt;J Neuroimmunol,2003
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24
2. The present and future of bispecific antibodies for cancer therapy;Nature Reviews Drug Discovery;2024-03-06
3. CrossFuse-XGBoost: accurate prediction of the maximum recommended daily dose through multi-feature fusion, cross-validation screening and extreme gradient boosting;Briefings in Bioinformatics;2023-11-22
4. XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models;Cancer Immunology, Immunotherapy;2023-10-21
5. Genes, inflammatory response, tolerance, and resistance to virus infections in migratory birds, bats, and rodents;Frontiers in Immunology;2023-08-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3